|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61P 37/06 |
| (11) | Number of the document | 1830857 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05856121.8 |
| Date of filing the European patent application | 2005-12-30 | |
| (97) | Date of publication of the European application | 2007-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2010-09-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/047666 |
| Date | 2005-12-30 |
| (87) | Number | WO 2006/072093 |
| Date | 2006-07-06 |
| (30) | Number | Date | Country code |
| 640178 P | 2004-12-30 | US |
| (72) |
McDONALD, George B., US
STERGIS, Nicholas, US
KANZER, Steve, US
|
| (73) |
Soligenix, Inc.,
1101 Brickell Avenue, Suite 701-S, Miami, FL 33131,
US
|
| (54) | BECLOMETHASONE DIPROPIONATE AND PREDNISONE FOR REDUCING MORTALITY ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE |
| BECLOMETHASONE DIPROPIONATE AND PREDNISONE FOR REDUCING MORTALITY ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE |